Sangamo Therapeutics
SGMO
#10491
Rank
$30.65 M
Marketcap
$0.07400
Share price
0.00%
Change (1 day)
-86.55%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2026 (TTM): -$0.12 Billion USD

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are $34.55 Million USD. In 2025 the company made an earning of -$0.11 Billion USD a decrease over its 2024 earnings that were of -$98.45 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -$0.12 Billion2.15%
2025 -$0.11 Billion9.71%
2024 -$98.45 Million-17.27%
2023 -$0.12 Billion-40.88%
2022 -$0.21 Billion9.79%
2021 -$0.19 Billion41.52%
2020 -$0.13 Billion23.17%
2019 -$0.11 Billion36.33%
2018 -$77.15 Million36.89%
2017 -$56.37 Million-22.32%
2016 -$72.56 Million54.86%
2015 -$46.86 Million75.62%
2014 -$26.69 Million0.13%
2013 -$26.65 Million
2011 -$35.83 Million43.66%
2010 -$24.94 Million28.52%
2009 -$19.41 Million-23.55%
2008 -$25.38 Million2.45%
2007 -$24.78 Million19.5%
2006 -$20.73 Million50.78%
2005 -$13.75 Million75%
2004 -$7.86 Million-33.25%
2003 -$11.77 Million-62.27%
2002 -$31.2 Million102.82%
2001 -$15.38 Million23.21%
2000 -$12.49 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
$25.97 B-23,648.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$9.08 B-8,336.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
$1.62 B-1,571.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-$2.53 Billion 2,190.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
$10.72 B-9,824.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$13.15 B-12,021.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
$0.86 B-888.30%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
$0.38 B-449.52%๐Ÿ‡บ๐Ÿ‡ธ USA